DAIHAN Scientific Co. Ltd Cash Flow-to-Debt Ratio
DAIHAN Scientific Co. Ltd cash flow-to-debt ratio. DAIHAN Scientific Co. Ltd (131220) has a Cash Flow-to-Debt Ratio of 0.03x as of September 2025, meaning its operating cash flow of ₩361.12 Million could theoretically repay 0% of its total liabilities (₩13.84 Billion) in one year. Check 131220 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of DAIHAN Scientific Co. Ltd (2012–2024)
Cash flow-to-debt ratio of DAIHAN Scientific Co. Ltd from 2012 to 2024. Historical debt coverage capacity for DAIHAN Scientific Co. Ltd across 12 annual periods. Check 131220 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
DAIHAN Scientific Co. Ltd Cash Flow-to-Debt Ratio by Year (2012–2024)
DAIHAN Scientific Co. Ltd cash flow-to-debt ratio by year from 2012 to 2024. Year-by-year debt coverage analysis for DAIHAN Scientific Co. Ltd. For the full cash flow conversion analysis, see cash flow conversion of DAIHAN Scientific Co. Ltd.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.16x | ₩3.99 Billion | ₩25.59 Billion | ▼ -19.4% |
| 2023 | 0.19x | ₩4.79 Billion | ₩24.80 Billion | ▼ -1.4% |
| 2022 | 0.20x | ₩4.51 Billion | ₩23.02 Billion | ▲ +5.8% |
| 2021 | 0.19x | ₩4.13 Billion | ₩22.29 Billion | ▼ -45.4% |
| 2020 | 0.34x | ₩5.35 Billion | ₩15.74 Billion | ▲ +125.6% |
| 2019 | 0.15x | ₩2.44 Billion | ₩16.20 Billion | ▼ -46.4% |
| 2018 | 0.28x | ₩3.76 Billion | ₩13.39 Billion | ▼ -21.0% |
| 2017 | 0.36x | ₩4.58 Billion | ₩12.89 Billion | ▲ +50.4% |
| 2016 | 0.24x | ₩4.12 Billion | ₩17.45 Billion | ▲ +361.2% |
| 2015 | 0.05x | ₩898.12 Million | ₩17.53 Billion | ▼ -63.1% |
| 2014 | 0.14x | ₩2.59 Billion | ₩18.66 Billion | ▲ +260.3% |
| 2012 | 0.04x | ₩565.94 Million | ₩14.69 Billion | — |